Gabriella Schraner
Wallbach
Joint signing authority (any two to sign)
Sachiaki Ibe
Tokyo, JP
Chairperson of the board
Joint signing authority (any two to sign)
Thomas Tóth
Bottmingen
Managing member of the board + chairperson of the management board
Joint signing authority (any two to sign)
Mitsuhiro Ibe
Tokyo, JP
Member of the board
Joint signing authority (any two to sign)
Mattias Norrman
Sigtuna, SE
Member of the board
Joint signing authority (any two to sign)
Harald Haubitz
Hausen im Wiesental, DE
Joint signing authority (any two to sign)
Oliver Isch
Fislisbach
Joint signing authority (any two to sign)
Masakazu Sakurai
Tokyo, JP
Member of the board
Joint signing authority (any two to sign)
Adrian Hill
Zug
Member of the management board
Joint signing authority (any two to sign)
Johann Spleiss
Ziefen
Member of the management board
Joint signing authority (any two to sign)
Sandra Annani
Stetten
Joint signing authority (any two to sign)
Christian Weidenfeller
Fällanden
Joint signing authority (any two to sign)
Mirjam von Zedtwitz
Zürich
Sekretärin (nichtmitglied)
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 3526 | 03.03.2026 | 1006589118 | 06.03.2026 | 1006589118 |
| 2 | 1099 | 19.01.2026 | 1006547011 | 22.01.2026 | 1006547011 |
| 3 | 16266 | 02.12.2024 | 1006196150 | 05.12.2024 | 1006196150 |
| 4 | 15633 | 19.11.2024 | 1006185782 | 22.11.2024 | 1006185782 |
| 5 | 13724 | 09.10.2024 | 1006153448 | 14.10.2024 | 1006153448 |
| 6 | 3094 | 27.02.2024 | 1005975219 | 01.03.2024 | 1005975219 |
| 7 | 15957 | 21.11.2023 | 1005893485 | 24.11.2023 | 1005893485 |
| 8 | 6237 | 25.04.2023 | 1005734829 | 28.04.2023 | 1005734829 |
| 9 | 1540 | 25.01.2023 | 1005664891 | 30.01.2023 | 1005664891 |
| 10 | 6299 | 18.05.2021 | 1005188983 | 21.05.2021 | 1005188983 |
Die Gesellschaft bezweckt die Entwicklung, die Herstellung, den Vertrieb sowie die Vermarktung von pharmazeutischen Produkten. Sie kann alle Geschäfte tätigen, die mit dem Hauptzweck direkt oder indirekt zusammenhängen und Vermögensanlagen anderer Art tätigen.
